On World Cancer Day, meet a few of the EIT Community entrepreneurs that are fighting cancer with their innovations.
World Cancer Day is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education and catalysing personal, collective and governmental action, they work together to reimagine a world where millions of people are saved from preventable cancer and access to life-saving cancer treatment and care is equal for all.
Through life-changing innovations, the EIT Community is taking part in tackling this challenge. Meet three of our EIT Award nominees from the past years and learn how they are fighting cancer through their innovative and unique solutions.
Martin Boutiere - Nutr'Avenir
Cancer patients are commonly fed with high protein diets to tackle malnutrition and this implies a risk of tumour growth. Nutr’Avenir is a preclinical platform focused on nutrition for cancer patients undergoing chemotherapy.
There is no other existing enteral nutrition research platform of this kind. The project will reduce morbidity and mortality among cancer patients undergoing chemotherapy. It will enable caregivers to positively affect the health conditions, recovery rate, and quality of life of their patients. Healthcare systems will subsequently benefit from a successful and economically effective option for cancer treatment.
In 2020, Martin Boutiere won second place in the EIT CHANGE Award, the award that recognises graduates of EIT education programmes who spur innovation and entrepreneurship, inspiring change for a sustainable future. Martin completed his EIT-labelled Master in Technological Innovation in Health at the University of Grenoble Alpes.
Maria Sievert - Inveox
Inveox solves the single biggest problem and safety risk in histopathology by introducing the world’s first automation system for sample entry. By using big data and Artificial Intelligence, Inveox is making cancer diagnosis faster and safer.
Between one and fifteen per cent of tissue samples are vulnerable to mix-ups, contamination, or getting lost. This can lead to false-positives and false-negatives. Inveox's products are designed to prevent that from happening.
Laura Soucek - Peptomyc
The protein Myc is found in most human cancers and plays a significant role in the growth of new tumours. It is difficult to attack with drugs due to its location in the nuclei of the cells and its role in the division of healthy cells.
Peptomyc relies on peptides, another fundamental component of the cell, to create therapeutics able to fight these Myc proteins. Peptomyc's peptide-based solution is a new treatment option for cancer options. The treatment is non-toxic, does not cause resistance, improves life-expectancy among patients, and can be used in combination with standard chemotherapy or immunotherapy.